SC 13G Filing

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

April 7, 2015

Accession Number

0001319244-15-000025

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →